J&J slashes third-quarter profit by $3 billion over proposed opioid deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein
October 25, 2019 8:48 AM EDTBernstein analyst Lee Hambright highlights that Johnson & Johnson (NYSE: JNJ) has lost $23 billion in market cap since October 18th, when the company announced a voluntary baby powder recall (33,000 bottles) after the FDA found asbestos at 0.00002% concentration in a sample from a single bottle purchased... More
